HomeCompareLDXHF vs PLD

LDXHF vs PLD: Dividend Comparison 2026

LDXHF yields 1238.39% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LDXHF wins by $124493855.63M in total portfolio value
10 years
LDXHF
LDXHF
● Live price
1238.39%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$124493861.54M
Annual income
$107,429,031,462,338.22
Full LDXHF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — LDXHF vs PLD

📍 LDXHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLDXHFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LDXHF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LDXHF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LDXHF
Annual income on $10K today (after 15% tax)
$105,263.16/yr
After 10yr DRIP, annual income (after tax)
$91,314,676,742,987.48/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, LDXHF beats the other by $91,314,672,704,871.08/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LDXHF + PLD for your $10,000?

LDXHF: 50%PLD: 50%
100% PLD50/50100% LDXHF
Portfolio after 10yr
$62246933.72M
Annual income
$53,714,518,106,531.70/yr
Blended yield
86.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

LDXHF
No analyst data
Altman Z
-3.3
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LDXHF buys
0
PLD buys
0
No recent congressional trades found for LDXHF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLDXHFPLD
Forward yield1238.39%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$124493861.54M$5.91M
Annual income after 10y$107,429,031,462,338.22$4,750,725.19
Total dividends collected$123225412.32M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: LDXHF vs PLD ($10,000, DRIP)

YearLDXHF PortfolioLDXHF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$134,539$123,839.01$11,241$540.96+$123.3KLDXHF
2$1,701,076$1,557,119.40$13,019$991.13+$1.69MLDXHF
3$20,219,975$18,399,823.95$15,801$1,870.97+$20.20MLDXHF
4$226,038,135$204,402,761.69$20,609$3,701.21+$226.02MLDXHF
5$2,377,382,925$2,135,522,120.49$29,919$7,867.97+$2377.35MLDXHF
6$23,535,021,639$20,991,221,908.63$50,631$18,617.74+$23534.97MLDXHF
7$219,391,496,761$194,209,023,607.94$105,528$51,352.20+$219391.39MLDXHF
8$1,926,711,724,815$1,691,962,823,279.82$287,364$174,449.42+$1926711.44MLDXHF
9$15,948,439,325,295$13,886,857,779,743.26$1,081,760$774,280.77+$15948438.24MLDXHF
10$124,493,861,540,404$107,429,031,462,338.22$5,908,209$4,750,725.19+$124493855.63MLDXHF

LDXHF vs PLD: Complete Analysis 2026

LDXHFStock

Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.

Full LDXHF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this LDXHF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LDXHF vs SCHDLDXHF vs JEPILDXHF vs OLDXHF vs KOLDXHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.